Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Acta Clinica Belgica|January 6, 2021
Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health careViviane Van Hoof, Dragos Barglazan, Laurent Blairon, et al.
Annales D'Endocrinologie|January 18, 2018
SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbookYves Reznik, Pascal Barat, Jérôme Bertherat, et al.
Ebiomedicine|August 9, 2024
Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research projectAnne-Catherine Pouleur, Nassiba Menghoum, Julien Cumps, et al.
Ebiomedicine|February 26, 2022
Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patientsVirginie Montiel, Irina Lobysheva, Ludovic Gérard, et al.
Research and Practice in Thrombosis and Haemostasis|February 2, 2026
Platelet lipidome alterations in septic shock: a matched case-control studyEmma de Cartier d'Yves, Melanie Dechamps, Jérôme Ambroise, et al.
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
Frontiers in Medicine|February 3, 2022
Inflammation-Induced Coagulopathy Substantially Differs Between COVID-19 and Septic Shock: A Prospective Observational StudyMélanie Dechamps, Julien De Poortere, Manon Martin, et al.
Autoimmunity Reviews|July 6, 2010
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practiceJean-Claude Souberbielle, Jean-Jacques Body, Joan M Lappe, et al.
JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Clinical Chemistry and Laboratory Medicine|October 5, 2012
The EC4 European syllabus for post-graduate training in clinical chemistry and laboratory medicine: version 4--2012Gijsbert Wieringa, Simone Zerah, Rob Jansen, et al.
Pageof 21